SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject4/18/2002 2:48:24 AM
From: sim1   of 631
 
Inflammation & Protein Kinases in Drug Discovery & Development
Meeting To be Held June 24-25 Princeton, NJ
PR Newswire - USA; Apr 17, 2002

The world inflammatory disease research community will be convening in
Princeton, NJ to attend, speak, and exhibit at "Inflammation in Drug
Discovery & Development," announces Strategic Research Institute. This
conference will explore in detail -- research efforts to discover and develop
safer and more effective therapies of rheumatoid arthritis and other
inflammatory diseases & programs intended to generate next generation
anti-inflammatory drugs.

The conference is organized into 4 main sections: 1) Novel Anti-TNF
Proteins, 2) Advances in Small Molecule Anti-TNF Inhibitors, 3)IL-1
Receptors & Receptor Antagonists & 4) Additional Approaches for Novel
Anti-Inflammatory Drugs. Featured topics on program include TNF blockers,
BAFF, TACE Inhibitors, IRAK, p38 Kinase Inhibitors, Kineret, JNK
Inhibitors, ICE, Traps, IKK, IL-2 Receptor Antibody, NFkB Pathway, etc.

Participants include: Abbott Laboratories, Amgen, Biogen, Celgene,
Immunex, Merck Research Labs, National Institutes of Health, Nereus
Pharmaceuticals Pharmacia Corporation, Pfizer Global R & D - Groton
Labs, Protein Design Labs, Regeneron Pharmaceuticals, Roche Bioscience
Johnson & Johnson PRI, Scios Inc., Temple University, Vertex
Pharmaceuticals, & Wyeth Research II. To date 60 individuals have signed
up for the meeting. Please remember the EARLY registration discount ends
on JUNE 26TH!!

To request the agenda, please contact Ed Drilon at edrilon@srinstitute.com
or 212-967-0095 x233. Include your fax number, affiliation and mailing
address.

To register for the exposition or inquire about sponsorship opportunities to
augment your company's on-site exposure to prospective clients and
collaborators totebags, coffee mugs, luncheons, reception), please contact
Mark Alexay at malexay@srinstitute.com.

MAKE YOUR OPINION COUNT - Click Here
tbutton.prnewswire.com Strategic Research
Institute

Contact: Ed Drilon, edrilon@srinstitute.com, +1-212-967-0095 x233, or
Mark Alexay, malexay@srinstitute.com, both of Strategic Research
Institute

Website: srinstitute.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext